New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
September 27, 2010
14:19 EDTHSP, MCK, ABC, SNYRumor: Pharma Distributors move up on speculation of a positive court ruling
Shares of Hospira (HSP), McKesson (MCK) and AmerisourceBergen (ABC) are moving higher on conjecture that a District Court declared Sanofi's patents invalid, clearing the way for generic Taxotere.
News For HSP;MCK;ABC;SNY From The Last 14 Days
Check below for free stories on HSP;MCK;ABC;SNY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
July 30, 2014
09:00 EDTMCKMcKesson extends pharmaceutical distribution agreement with CVS Caremark
McKesson Corporation (MCK) announced a three-year extension of its existing distribution agreement with CVS Caremark (CVS) through June, 2019. “We have a long track record of delivering comprehensive supply chain solutions to CVS Caremark which in turn allows CVS Caremark to ensure the highest level of pharmaceutical care to its customers,” said Paul Julian, executive vice president, group president, McKesson Corporation. “We are pleased to have extended our agreement with CVS Caremark and continue our long standing partnership.”
08:08 EDTSNYSanofi and Regeneron report positive Phase 2 results of alirocumab
Subscribe for More Information
07:35 EDTHSPHospira sees FY14 adjusted EPS $2.30-$2.50, consensus $2.22
Raises FY14 cash flow from operations to $275M-$375M from $200M-$300M; Backs FY14 CapEx $375M-$425M; Backs FY14 depreciation and amortization to range $225M-$275M.
07:34 EDTHSPHospira reports Q2 adjusted EPS 72c, consensus 57c
Subscribe for More Information
July 29, 2014
15:53 EDTHSPNotable companies reporting before tomorrow's open
Subscribe for More Information
07:19 EDTHSPCBI to hold a conference
Subscribe for More Information
July 28, 2014
12:42 EDTHSPHospira, Danone rise following report of deal talks
Subscribe for More Information
09:02 EDTSNYSanofi, InnerWorkings sign global marketing partnership
Subscribe for More Information
08:12 EDTHSPHospira to obtain financial benefits from possible Danone deal, says Wells Fargo
After multiple media sources reported that Hospira (HSP) is in talks to buy Danone's (DANOY) medical nutrition business in a potential tax inversion deal, Wells Fargo estimates that the deal could be 9%-12% accretive to Hospira's EPS in 2015-2017 if it's an all-stock deal and 20%-22% accretive if it's a 50%/50% cash and stock deal. The firm The firm estimates that Hospira's tax bill would be cut to 21% in 2015 and 19% afterwards, from its current forecast of 24%-26% during those years. The firm thinks the strategic rationale for the deal from Hospira's perspective, however, is less clear. It keeps a Market Perform rating on the stock.
07:26 EDTMCKAmerican Association for Clinical Chemistry to hold annual meeting
Subscribe for More Information
July 27, 2014
15:12 EDTHSP Hospira in talks to acquire Danone medical nutrition business, FT says
French consumer company Danone (DANOY) has been in negotiations to sell its medical nutrition business to Hospira (HSP) in a deal said to value the unit at $5B, says the Financial Times. The deal would also allow for U.S. based Hospira to domicile its tax base in Europe in a tax strategy known as an inversion, added the Financial Times. In prior reports, Nestle (NSRGY) and Fresenius (FMS) have also been mentioned as suitors for the Danone unit. Reference Link
July 25, 2014
10:55 EDTABCHigh option volume stocks
Subscribe for More Information
09:28 EDTABCCardinal Health has good read through from AmerisourceBergen, says Sterne Agee
Sterne Agee believes that AmericansourceBergen's (ABC) beat and raise results bode well for Cardinal Health (CAH). The firm keeps a Buy rating on Cardinal.
July 24, 2014
07:03 EDTABCAmerisourceBergen now sees FY14 adjusted continuing ops EPS $3.89-$3.94
Consensus is $3.73. Sees FY14 revenue growth in the 35% range, consensus $116.72B. The company says "Adjusted operating margin is expected to decline in the high-teens basis points range due to the onboarding of significant new lower margin business and growth in brand pharmaceutical business with our large customers. We expect free cash flow to be in the high end of the range of $500 to $700 million, with capital expenditures in the $275 million range, and to spend approximately $500 million in share repurchases, subject to market conditions."
07:02 EDTABCAmerisourceBergen reports Q3 continuing ops EPS $1.01, consensus 92c
Reports Q3 revenue $30.35B, consensus $29.25B.
July 23, 2014
10:02 EDTHSPOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:10 EDTHSPDeutsche Bank hosts an analyst Specialty Pharma/Industry conference call
Subscribe for More Information
July 22, 2014
16:08 EDTHSPHospira initiated with a Hold at Deutsche Bank
Target $53.
July 21, 2014
07:11 EDTSNYInternational Society of DNA Vaccines to hold a conference
Subscribe for More Information
July 18, 2014
10:48 EDTHSPHigh option volume stocks
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use